Lakefront Biotherapeutics | GLPG - Capitaux Propres Et Réserves





Capitaux Propres Et Réserves Changement Date
argenx SE USD 8.42B 1.09B 2026-06
AstraZeneca USD 50.3B 2.96B 2026-06
Biogen USD 18.85B 196.3M 2026-06
Genmab DKK 5.96B 275M 2026-06
Gilead Sciences USD 11.74B 11.77B 2026-06
GlaxoSmithKline GBP 17.64B 223M 2026-06
GRIFOLS EUR 7.98B 2.52B 2026-06
Hikma Pharmaceutical USD 2.59B 42M 2025-12
Incyte USD 6.34B 721.58M 2026-06
Merck EUR 30.17B 430M 2026-06
Neurocrine Biosciences USD 3.69B 286.2M 2026-06
Novartis USD 41.95B 3.02B 2026-06
Roche Holding CHF 32.69B 1.11B 2026-06
Sanofi EUR 69.57B 3.24B 2026-06
UCB EUR 10.87B 1.18B 2025-12
Vertex Pharmaceuticals USD 20.25B 886M 2026-06